N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine

C35H43FN6O3 — CID 144862289

IUPACN-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine
SMILESC=CNN.CCC[C@@H](CCNC(=O)c1cn2c3c(c(N4CC[C@@H](C)C4)c(F)cc3c1=O)Oc1cc3ccccc3cc1-2)N(C)C
InChIInChI=1S/C33H37FN4O3.C2H6N2/c1-5-8-23(36(3)4)11-13-35-33(40)25-19-38-27-15-21-9-6-7-10-22(21)16-28(27)41-32-29(38)24(31(25)39)17-26(34)30(32)37-14-12-20(2)18-37;1-2-4-3/h6-7,9-10,15-17,19-20,23H,5,8,11-14,18H2,1-4H3,(H,35,40);2,4H,1,3H2/t20-,23+;/m1./s1
InChIKeyOCLVJHOGCNTOHD-ZOLWKPHLSA-N
MW614.77 g/mol
LogP5.68
Rot. Bonds9

About N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine

N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine (PubChem CID 144862289) has the molecular formula C35H43FN6O3 and a molecular weight of 614.77 g/mol. Its IUPAC name is N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine.

Molecular Properties

Compound NameN-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine
PubChem CID144862289
Molecular FormulaC35H43FN6O3
Molecular Weight614.77 g/mol
Exact Mass614.34
IUPAC NameN-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine
SMILESC=CNN.CCC[C@@H](CCNC(=O)c1cn2c3c(c(N4CC[C@@H](C)C4)c(F)cc3c1=O)Oc1cc3ccccc3cc1-2)N(C)C
InChIInChI=1S/C33H37FN4O3.C2H6N2/c1-5-8-23(36(3)4)11-13-35-33(40)25-19-38-27-15-21-9-6-7-10-22(21)16-28(27)41-32-29(38)24(31(25)39)17-26(34)30(32)37-14-12-20(2)18-37;1-2-4-3/h6-7,9-10,15-17,19-20,23H,5,8,11-14,18H2,1-4H3,(H,35,40);2,4H,1,3H2/t20-,23+;/m1./s1
InChIKeyOCLVJHOGCNTOHD-ZOLWKPHLSA-N
XLogP5.68
TPSA104.86 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500614.77
LogP ≤ 55.68
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine?
The IUPAC name of N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine (CID 144862289) is N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine.
What is the SMILES notation for N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine?
The canonical SMILES for N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine is C=CNN.CCC[C@@H](CCNC(=O)c1cn2c3c(c(N4CC[C@@H](C)C4)c(F)cc3c1=O)Oc1cc3ccccc3cc1-2)N(C)C.
What is the InChIKey of N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine?
The InChIKey is OCLVJHOGCNTOHD-ZOLWKPHLSA-N. The full InChI is InChI=1S/C33H37FN4O3.C2H6N2/c1-5-8-23(36(3)4)11-13-35-33(40)25-19-38-27-15-21-9-6-7-10-22(21)16-28(27)41-32-29(38)24(31(25)39)17-26(34)30(32)37-14-12-20(2)18-37;1-2-4-3/h6-7,9-10,15-17,19-20,23H,5,8,11-14,18H2,1-4H3,(H,35,40);2,4H,1,3H2/t20-,23+;/m1./s1.
What are the key properties of N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine?
N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine has a molecular weight of 614.77 g/mol, XLogP of 5.68, 9 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-3-(dimethylamino)hexyl]-15-fluoro-14-[(3R)-3-methylpyrrolidin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide;ethenylhydrazine is sourced from PubChem (CID 144862289), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).